Shoulder Innovations Q2 operating loss widens to $10.04 million; revenue rises 56% to $17.2 million

Reuters2026/08/06 20:22

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Shoulder Innovations posted Q2 net revenue of USD 17.2 million, up 56% year over year; net loss narrowed to USD 10.2 million.
Gross margin rose 2.1 percentage points to 78.3%; average selling price climbed 5% to USD 7,674.
Implant systems sold increased 50% to 2,238; operating loss widened to USD 10 million.
Launched the N-22 glenosphere for metal hypersensitivity patients; rolled out a titanium plasma spray baseplate line extension for reverse procedures.
Raised full-year net revenue guidance to USD 67 million-USD 69 million; CEO Rob Ball cited momentum in surgeon onboarding and utilization.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shoulder Innovations Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Shoulder Innovations Q2 operating loss widens to $10.04 million; revenue rises 56% to $17.2 million

You may also like

Crypto prices